BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1629 related articles for article (PubMed ID: 32111213)

  • 1. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
    Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
    Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer.
    Zhu X; Bu F; Tan T; Luo Q; Zhu J; Lin K; Huang J; Luo C; Zhu Z
    J Exp Clin Cancer Res; 2020 Oct; 39(1):207. PubMed ID: 33023613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
    Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
    J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1.
    Liu T; Wang H; Fu Z; Wang Z; Wang J; Gan X; Wang A; Wang L
    Cancer Sci; 2022 Feb; 113(2):446-458. PubMed ID: 34813676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2'-O-methylation via NOP58 recruitment in colorectal cancer.
    Wu H; Qin W; Lu S; Wang X; Zhang J; Sun T; Hu X; Li Y; Chen Q; Wang Y; Zhao H; Piao H; Zhang R; Wei M
    Mol Cancer; 2020 May; 19(1):95. PubMed ID: 32443980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferritin Light Chain (FTL) competes with long noncoding RNA Linc00467 for miR-133b binding site to regulate chemoresistance and metastasis of colorectal cancer.
    Li Z; Liu J; Chen H; Zhang Y; Shi H; Huang L; Tao J; Shen R; Wang T
    Carcinogenesis; 2020 Jun; 41(4):467-477. PubMed ID: 31675755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA.
    Meng L; Lin H; Huang X; Weng J; Peng F; Wu S
    Cell Death Dis; 2022 Jan; 13(1):38. PubMed ID: 35013106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
    Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
    J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of long non-coding RNA RP11-708H21.4 is associated with poor prognosis for colorectal cancer and promotes tumorigenesis through regulating AKT/mTOR pathway.
    Sun L; Jiang C; Xu C; Xue H; Zhou H; Gu L; Liu Y; Xu Q
    Oncotarget; 2017 Apr; 8(17):27929-27942. PubMed ID: 28427191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization.
    Chen C; Yuan W; Zhou Q; Shao B; Guo Y; Wang W; Yang S; Guo Y; Zhao L; Dang Q; Yang X; Wang G; Kang Q; Ji Z; Liu J; Sun Z
    Theranostics; 2021; 11(9):4298-4315. PubMed ID: 33754062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SNHG5 affects cell proliferation, metastasis and migration of colorectal cancer through regulating miR-132-3p/CREB5.
    Zhang M; Li Y; Wang H; Yu W; Lin S; Guo J
    Cancer Biol Ther; 2019; 20(4):524-536. PubMed ID: 30395767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. m
    Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
    Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of the long noncoding RNA expression profile and construction of the lncRNA-mRNA co-expression network in colorectal cancer.
    Zhang Q; Ding Z; Wan L; Tong W; Mao J; Li L; Hu J; Yang M; Liu B; Qian X
    Cancer Biol Ther; 2020; 21(2):157-169. PubMed ID: 31619123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
    Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
    J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET.
    Wang S; Qiu J; Liu L; Su C; Qi L; Huang C; Chen X; Zhang Y; Ye Y; Ding Y; Liang L; Liao W
    J Exp Clin Cancer Res; 2020 Aug; 39(1):168. PubMed ID: 32843066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.
    Gao S; Liu H; Hou S; Wu L; Yang Z; Shen J; Zhou L; Zheng SS; Jiang B
    Clin Transl Oncol; 2018 Jun; 20(6):703-712. PubMed ID: 29071516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
    Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
    Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 82.